Sudeep Pharma Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakhs)
Sudeep Pharma Ltd · Outcome · 28 Oct 2026, 10:17 pm
Sudeep Pharma Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakhs) ■ Revenue: 19,670 (+20.9% YoY | +24.3% QoQ) ■ EBITDA: 7,324 (+32.1% YoY | +33.4% QoQ) ■ EBITDA Margin (%): 37.2 (+314 bps YoY | +254 bps QoQ) ■ PAT: 5,145 (+12.5% YoY | +26.9% QoQ) ■ EPS (INR): 4.59 (+9.3% YoY | +27.9% QoQ) Sudeep Pharma Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakhs) Segmental Performance Pharmaceutical, food and nutrition ■ Revenue: 14,250 (+57.5% YoY | +31.4% QoQ) ■ EBIT: 5,512 (+99.2% YoY | +37.7% QoQ) ■ EBIT Margin (%): 38.7 (+811 bps YoY | +176 bps QoQ) Speciality ingredients ■ Revenue: 5,420 (-24.9% YoY | +8.7% QoQ) ■ EBIT: 1,274 (-46.9% YoY | +17.0% QoQ) ■ EBIT Margin (%): 23.5 (-973 bps YoY | +167 bps QoQ)
Original exchange filing (PDF)
More announcements from Sudeep Pharma Ltd
- Submission of Transcript for the Earnings call held on 29.10.2026 · 03 Nov 2026
- Submission of Audio Recording of the Earnings call held on 29th October 2026 · 29 Oct 2026
- Submission of Investors Presentation · 29 Oct 2026
- Outcome of Board Meeting · 28 Oct 2026
- Submission of Unaudited Financials Results for the Quarter and half year ended 30th September 2026 · 28 Oct 2026
- Press Release - FDA Approval for the new pharma greenfield manufacturing facility at 179 Nandesari, Gujarat. · 26 Oct 2026
- Intimation for the Investor Meet Scheduled to be held on 29th October 2026 at 12:00 noon. · 29 Oct 2026
- To consider and approve the financial results for the period ended September 30, 2026 and other business matters · 28 Oct 2026
